Lloyd Fonds AG has adopted important steps for the further implementation of Strategy 2019+. Subject to the approval of the shareholders at the annual general meeting, Lloyd Fonds AG will be acquiring 90% of the shares in SPSW Capital GmbH.
With immediate effect, Lloyd Fonds AG (Deutsche Börse Scale, ISIN DE000A12UP29) will commence selling operations for its first four investment funds comprising two equity funds, one mixed fund and one bond fund.
Company aims to be ready to launch this trial as second therapeutic approach developed for solid tumorse in Q2-2019
Data complements previously published results showing activity of NOX-E36 in pancreatic cancer
Lloyd Fonds AG ended the 2018 financial year with two successful real estate transactions. Pre-tax return of between 10 and 11.5 percent for fund investors
Findings include stable disease and prolonged time on treatment vs. prior therapy in heavily pretreated metastatic pancreatic and colorectal cancer patients
Acquisition of asset management company Lange Assets & Consulting GmbH. Money-market oriented fund to become part of the Lloyd Fonds retail funds
Acknowledged equity and fixed-income specialists will manage successful strategies in the new mutual fund as part of the LF line. New Sales office in Munich
NOXXON ends the use of variable rate equity financing with Yorkville
Michael Schmidt, CFA, appointed Chief Investment Officer (CIO) of Lloyd Fonds AG from April 1st, 2019.
New Branch to be opened in Munich this year